AMERICAN NEUROTOLOGY SOCIETY
The 45th Annual Spring Meeting
Paris/Bally’s Las Vegas
Las Vegas, NV
May 1 – May 2, 2010

Deadline for abstract submission: October 15, 2009

The abstract submission form is now closed, thank you for your abstracts.

The Electronic Abstract Submission Form will be available July 1, 2009

Click here to download a pdf file of the abstract instructions


Abstract Submission Instructions: Please read all instructions carefully. Failure to comply with the instructions could delay the review of and/or disqualify your abstract submission. Please contact Kristen Bordignon, ANS Administrator if you have any questions prior to submitting your abstract.
Email: neurotology65@yahoo.com
Ph: 217-638-0801
Fax: 217-438-6404

The American Neurotology Society accepts on-line submission of abstracts to www.americanneurotologysociety.com

The electronic version is not to contain any extraneous formatting instructions.
Acknowledgment of receipt of an electronic submission will be sent electronically during the submission process to the primary author.

The ANS Scientific Program Committee will not consider abstracts that do not contain the required elements.

Abstracts must be structured according to Otology & Neurotology Guidelines for Authors

General Format:
A concise abstract of not more than 250 words or less is required for all original clinical and basic science contributions, including review articles. The ANS Scientific Program Committee reviews all abstracts anonymously; please do not place any identifying information in the body of the abstract, such as referral to authorship or institution. Also, if the research in
your paper is supported by a grant, or special financial arrangement, this must be identified.

These should be organized according to the headings outlined below. The author(s) must accept sole responsibility for statements in their submitted abstract.

Choose an appropriate title reflecting the content of the abstract body, as this title will appear in all publications if chosen for presentation. Do not capitalize prepositions, a, an, the, etc. Do not include the author’s name(s) in the abstract title or body.

List all authors in proper sequence (numbering 1, 2, 3, etc., if applicable) using first names, middle initials, and last names and exact designations (i.e. MD, PhD, MS, etc.) Specify the primary author and the presenter of the abstract. Please specify a corresponding author to whom all correspondence about the abstract will be directed.

The American Neurotology Society requires a completed manuscript to Otology & Neurotology Journal and an electronic copy to the ANS Administrative office a minimum of three weeks before the scientific program in order for the ANS Scientific Program Committee to review the manuscript for any commercial bias, conflict of interest, use of commercial names and any other identifying information that may conflict with the ACCME requirements.

The program committee may ask you to revise submitted abstract to ensure compliance with the ACCME requirements. Failure to comply will result in the removal of your presentation from the ANS Scientific Program.

For clinical studies:
Objective: Brief, clear statement of the main goals of the investigation.
Study design: Specify the type of study-randomized, prospective double blind; retrospective case review; etc.
Setting: Primary care vs. Tertiary referral center; ambulatory vs. hospital; etc.
Patients: Primary eligibility criteria and key demographic features.
Intervention(s): Diagnostic, therapeutic, and/or rehabilitative.
Main outcome measure(s): The most essential criterion that addresses the study’s central hypothesis.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated from this study.

For basic science reports:
Hypothesis: Brief, clear statement of the main goals of the investigation.
Background: Concise orientation for the reader unfamiliar with this line of investigation.
Methods: Succinct summary of techniques and materials employed.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated from this study.
Emphasize clinical relevance wherever possible.

For reviews and meta-analysis:
Objective: Brief, clear statement of the goals of the review.
Data sources: Specify database, search methodology, languages covered, and time frame.
Study selection: Criteria used to select articles for detailed review.
Data extraction: Means of assessing quality, validity, and comparability of extracted data.
Data synthesis: Specify statistical techniques used for data analysis.
Conclusions: Concise statement of primary inferences with any recommendations.
For All Human Studies: Indicate IRB Approval Number
Support/Acknowledgment:

Author Responsibility/Financial Disclosure/Conflict of Interest & Attestation Form:
All authors (primary and contributing) are responsible for disclosing any potential conflict of interest. Conflict of interest of an individual has two components: 1) a financial relationship with a commercial interest (e.g., pharmaceutical company or medical device manufacturer) and, 2) the opportunity to influence content of a CME activity relevant to products and services of that commercial interest In addition, all authors must agree to disclose all non-FDA approved use of FDA approved drugs at the time of abstract submission and prior to the actual oral presentation should your abstract be selected for presentation.

In order to comply with the ACCME requirements, all primary and contributing authors are required to complete a financial Disclosure/Conflict of Interest & Attestation form at the time of abstract submission.

Click here to fill out the Conflict of Interest/Disclosure & Attestation form and submit electronically. The primary author accepts responsibility to secure conflict of interest/disclosure statements from all co-authors. If you do not have an electronic signature, please fax your completed form with full name, designation and signature to the ANS Administrative office at 217-438-6404.

Identification of Professional Practice Gaps and Educational Need is a new aspect of the abstract submission this year

Professional practice gaps are the variations or differences in the practice patterns of physicians when compared to current evidence, standards of care or clinical guidelines that are designed to provide quality of care to patients.

Describe how you translate identified professional practice gaps into educational needs. How the need is expressed in terms of knowledge, competence, performance and patient outcome. What should the learners be able to apply to their profession after they participate in the educational activity? Lastly, list the desired results in terms of changes in physician knowledge, competence, performance, or patient outcome.

For an example of the new, updated abstract submission process, click here